WNT5A and gastric cancer: Furthermore, the treatment of GC cells with a polyclonal Wnt5a antibody (pAb5a-5) decreased cell adhesion, migration, and invasion of GC cell lines in vitro, and reduced the metastatic activity of the GC cell line KKLS in vivo (Hanaki et al., 2012).